Deme Karikios

1.1k total citations
50 papers, 646 citations indexed

About

Deme Karikios is a scholar working on Oncology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Deme Karikios has authored 50 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Economics and Econometrics and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Deme Karikios's work include Economic and Financial Impacts of Cancer (18 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Advances in Oncology and Radiotherapy (8 papers). Deme Karikios is often cited by papers focused on Economic and Financial Impacts of Cancer (18 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Advances in Oncology and Radiotherapy (8 papers). Deme Karikios collaborates with scholars based in Australia, United Kingdom and Canada. Deme Karikios's co-authors include Martin R. Stockler, Nick Pavlakis, Christos S. Karapetis, Chris Brown, Karen Canfell, Brett Hughes, Anna K. Nowak, W. Joost Lesterhuis, Sonia Yip and Peey‐Sei Kok and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Deme Karikios

49 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deme Karikios Australia 15 290 284 125 73 59 50 646
Megan E.V. Caram United States 15 200 0.7× 255 0.9× 115 0.9× 45 0.6× 56 0.9× 73 580
Jinani Jayasekera United States 14 358 1.2× 218 0.8× 90 0.7× 33 0.5× 47 0.8× 58 642
Jaclyn Beca Canada 15 284 1.0× 204 0.7× 251 2.0× 41 0.6× 53 0.9× 58 691
Laura H. Hendrix United States 15 313 1.1× 273 1.0× 149 1.2× 30 0.4× 78 1.3× 39 733
Peh Joo Ho Singapore 13 408 1.4× 119 0.4× 64 0.5× 65 0.9× 38 0.6× 39 691
Aimee M. Near United States 16 438 1.5× 145 0.5× 69 0.6× 40 0.5× 35 0.6× 58 823
Jennifer L. Ersek United States 15 228 0.8× 221 0.8× 84 0.7× 59 0.8× 28 0.5× 28 649
Megan Coombes Canada 11 277 1.0× 144 0.5× 68 0.5× 112 1.5× 26 0.4× 16 624
Klazien Matter‐Walstra Switzerland 16 311 1.1× 178 0.6× 166 1.3× 41 0.6× 28 0.5× 40 580
Renee L. Gennarelli United States 12 496 1.7× 238 0.8× 128 1.0× 113 1.5× 41 0.7× 34 953

Countries citing papers authored by Deme Karikios

Since Specialization
Citations

This map shows the geographic impact of Deme Karikios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deme Karikios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deme Karikios more than expected).

Fields of papers citing papers by Deme Karikios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deme Karikios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deme Karikios. The network helps show where Deme Karikios may publish in the future.

Co-authorship network of co-authors of Deme Karikios

This figure shows the co-authorship network connecting the top 25 collaborators of Deme Karikios. A scholar is included among the top collaborators of Deme Karikios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deme Karikios. Deme Karikios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldsbury, David, Philip Haywood, Alison Pearce, et al.. (2024). Out‐of‐pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross‐sectional study. The Medical Journal of Australia. 221(2). 94–102. 2 indexed citations
2.
Alamgeer, Muhammad, et al.. (2024). Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey. Australian Critical Care. 37(4). 520–529. 2 indexed citations
3.
Bray, Victoria, et al.. (2024). Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists. Oncology. 102(8). 732–736. 2 indexed citations
4.
Bero, Lisa, et al.. (2023). Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 13(5). e065719–e065719. 1 indexed citations
5.
Krause, Martín, Georgina V. Long, Victoria Atkinson, et al.. (2023). Case series: Immune checkpoint inhibitor-induced transverse myelitis. Frontiers in Neurology. 14. 1130313–1130313. 14 indexed citations
6.
Jenei, Kristina, Adam Raymakers, Arnaud Bayle, et al.. (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology. 24(6). 624–635. 25 indexed citations
7.
McLoone, Jordana K., Raymond J. Chan, Megan Varlow, et al.. (2023). Challenges and solutions to cancer-related financial toxicity according to Australian health professionals: qualitative results from a national survey. Supportive Care in Cancer. 31(7). 441–441. 5 indexed citations
8.
Karikios, Deme, David Goldsbury, Stephen Wade, et al.. (2023). Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia. PharmacoEconomics. 41(11). 1525–1537. 2 indexed citations
9.
Cressman, Sonya, et al.. (2022). Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods. Lung Cancer. 166. 122–131. 9 indexed citations
10.
Agarwal, Anupriya, Deme Karikios, Martin R. Stockler, & Rachael L. Morton. (2022). Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia. PLoS ONE. 17(10). e0273620–e0273620. 3 indexed citations
11.
Wade, Stephen, et al.. (2022). Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia.. Value in Health. 25(9). 1634–1643. 6 indexed citations
12.
Wade, Stephen, Pavla Vaneckova, S. Behar Harpaz, et al.. (2022). Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening. Lung Cancer. 169. 47–54. 4 indexed citations
13.
Howle, Julie R., et al.. (2021). Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience. Journal of Medical Imaging and Radiation Oncology. 65(6). 760–767. 5 indexed citations
14.
Kirby, Emma, Alex Broom, Deme Karikios, Rosemary Harrup, & Zarnie Lwin. (2019). Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia. BMJ Open. 9(12). e032585–e032585. 5 indexed citations
15.
Wong, WK, Emma Kirby, Alex Broom, et al.. (2018). A mixed methods analysis of experiences and expectations among early‐career medical oncologists in Australia. Asia-Pacific Journal of Clinical Oncology. 14(5). e521–e527. 3 indexed citations
16.
Nowak, Anna K., Peey‐Sei Kok, W. Joost Lesterhuis, et al.. (2018). OA08.02 DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result. Journal of Thoracic Oncology. 13(10). S338–S339. 25 indexed citations
17.
Lwin, Zarnie, Alex Broom, David Sibbritt, et al.. (2018). The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology. Seminars in Oncology. 45(5-6). 284–290. 8 indexed citations
18.
McEvoy, Christopher R., Huei San Leong, Huiling Xu, et al.. (2018). SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response. npj Precision Oncology. 2(1). 9–9. 28 indexed citations
19.
Broom, Alex, WK Wong, Emma Kirby, et al.. (2016). A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability. PLoS ONE. 11(11). e0166302–e0166302. 19 indexed citations
20.
Cox, Keith, Deme Karikios, Jessica Roydhouse, & Kate White. (2013). Nurse-led supportive care management: a 6-month review of the role of a nurse practitioner in a chemotherapy unit. Australian Health Review. 37(5). 632–635. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026